Back
Veru, Inc. 10K Form
Sell
17
VERU
Veru, Inc.
Last Price:
$2.55
Seasonality Move:
5.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-13 | 10Q | VERU/Veru, Inc. Quarterly |
| 2020-05-13 | 10Q | VERU/Veru, Inc. Quarterly |
| 2020-02-12 | 10Q | VERU/Veru, Inc. Quarterly |
| 2019-12-12 | 10K | VERU/Veru, Inc. Annual |
| 2019-08-08 | 10Q | VERU/Veru, Inc. Quarterly |
| 2019-05-15 | 10Q | VERU/Veru, Inc. Quarterly |
Receive VERU News And Ratings
See the #1 stock for the next 7 days that we like better than VERU
VERU Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-6.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.31 |
| Price / Book: | 0.98 |
Profitability
| EPS (TTM): | -0.72780 |
|---|---|
| Net Income (TTM): | $-19.2M |
| Gross Margin: | $-152.1K |
| Return on Equity: | -81.05% |
| Return on Assets: | -54.18% |
Veru, Inc. Earnings Forecast
Key Veru, Inc. Financial Ratios
-
Per Share Earnings over the last 36 years have been positive in 19 years.
Veru, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | VERU |
| CUSIP: | 92536C |
| Website: | verupharma.com |
Debt
| Debt-to-Equity Ratio: | 0.08 |
|---|---|
| Current Ratio: | 5.16 |
| Quick Ratio: | 4.97 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VERU Technical Analysis vs Fundamental Analysis
Sell
17
Veru, Inc. (VERU)
is a Sell
Is Veru, Inc. a Buy or a Sell?
-
Veru, Inc. stock is rated a SellThe current Veru, Inc. [VERU] share price is $2.48. The Score for VERU is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.